“Characterization of ORKA-001, a Novel Extended Half-Life Monoclonal Antibody Targeting IL-23 for the Treatment of Psoriasis”. SKIN The Journal of Cutaneous Medicine 9, no. 2 (March 17, 2025): s527. Accessed May 21, 2025. https://skin.dermsquared.com/skin/article/view/3295.